スタッフ ログイン
Japanese |
English
ご質問・ご要望
一覧
検索
生物種別閲覧
登録
統計情報
検索
ホーム
一覧
論文
特許
論文 - 一覧
«
»
10 Hits
検索条件 : 絞込み (MeSH = Heterocyclic Compounds, 4 or More Rings / pharmacology*)
生物種
リソース名
RRC ID
タイトル
ジャーナル
公開日
外部リンク
ヒト・動物細胞
201B7(HPS0063)
,
253G1(HPS0002)
85756
Direct Reprogramming of Glioblastoma Cells into Neurons Using Small Molecules.
ACS Chem Neurosci
2018-12-19
Pubmed
Full text
ヒト・動物細胞
Ba/F3(RCB4476)
68837
Lamellarin 14, a derivative of marine alkaloids, inhibits the T790M/C797S mutant epidermal growth factor receptor.
Cancer Sci
2021-5-1
Pubmed
Full text
ヒト・動物細胞
StromaNKtert(RCB2350)
68562
The multi-kinase inhibitor TG02 induces apoptosis and blocks B-cell receptor signaling in chronic lymphocytic leukemia through dual mechanisms of action.
Blood Cancer J
2021-3-13
Pubmed
Full text
ヒト・動物細胞
PANC-1(RCB2095)
63562
Kuanoniamine C stimulates bortezomib-induced cell death via suppression of glucose-regulated protein 78 in osteosarcoma.
Biochem Biophys Res Commun
2020-6-18
Pubmed
Full text
ヒト・動物細胞
HeLa(RCB0007)
63268
Nucleolar translocation of human DNA topoisomerase II by ATP depletion and its disruption by the RNA polymerase I inhibitor BMH-21.
Sci Rep
2021-11-2
Pubmed
Full text
ヒト・動物細胞
DT40 Library
58899
Comparison of in vitro and in vivo biological effects of trabectedin, lurbinectedin (PM01183) and Zalypsis® (PM00104).
Int J Cancer
2013-11-1
Pubmed
Full text
ヒト・動物細胞
K562/Adr(RCB1898)
56053
A Pharmacological Strategy Using Stemofoline for more Efficacious Chemotherapeutic Treatments Against Human Multidrug Resistant Leukemic Cells.
Asian Pac J Cancer Prev
2018-12-25
Pubmed
Full text
ヒト・動物細胞
K562(RCB1897)
,
K562/Adr(RCB1898)
45319
Reversal of human multi-drug resistance leukaemic cells by stemofoline derivatives via inhibition of P-glycoprotein function.
Basic Clin Pharmacol Toxicol
2015-5-1
Pubmed
Full text
ヒト・動物細胞
HL60(RCB0041)
38529
Antiproliferative activity of xanthones isolated from Artocarpus obtusus.
J Biomed Biotechnol
2012-1-1
Pubmed
Full text
ヒト・動物細胞
MKN45(RCB1001)
17609
Antitumor activity of SNX-2112, a synthetic heat shock protein-90 inhibitor, in MET-amplified tumor cells with or without resistance to selective MET Inhibition.
Clin Cancer Res
2011-1-1
Pubmed
Full text